Related Experiment Video
Updated: Sep 6, 2025

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
Published on: March 3, 2023
A Novel Nonantibiotic Gut-directed Strategy to Prevent Surgical Site Infections
Sanjiv K Hyoju1, Robert Keskey1, Gerardo Castillo2
1Department of Surgery, University of Chicago, Chicago, IL.
A novel phosphate-rich polymer, Pi-PEG, effectively prevents surgical site infections (SSIs) in mice by modulating the gut microbiome. This non-antibiotic approach offers a promising alternative to traditional infection control methods.
Area of Science:
- Microbiology
- Immunology
- Polymer Science
Background:
- Gut microbiota dysbiosis and antibiotic use can lead to postoperative infections via the "Trojan Horse" mechanism.
- Pathogens from the gut can silently travel within immune cells to contaminate surgical sites.
Purpose of the Study:
- To evaluate the efficacy of orally delivered phosphate-rich polymer, Pi-PEG, in preventing surgical site infections (SSIs).
- To test Pi-PEG in a novel mouse model of spontaneous wound infection involving gut-derived pathogens.
Main Methods:
- Mice were fed either a standard or western-type diet and exposed to antibiotics.
- Pi-PEG was administered in drinking water to assess its impact on SSI incidence.
- Gut and wound microbiome composition was analyzed using amplicon sequence variant analysis.
Main Results:
- A western-type diet and antibiotic exposure promoted SSI pathogen growth in the gut and wound.
- Pi-PEG administration protected mice against SSIs.
- Protection was linked to modulation of the gut-wound microbiome.
Conclusions:
- Orally administered Pi-PEG prevents SSIs in a mouse model.
- Pi-PEG represents a sustainable, non-antibiotic strategy for surgical infection prevention.
- This approach may reduce reliance on increased sterility and broad-spectrum antibiotics.
Related Concept Videos
Hand hygiene
Hand washing...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Asepsis
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
